000877948 001__ 877948
000877948 005__ 20220930130245.0
000877948 0247_ $$2doi$$a10.3390/molecules25143193
000877948 0247_ $$2Handle$$a2128/25629
000877948 0247_ $$2pmid$$apmid:32668701
000877948 0247_ $$2WOS$$aWOS:000557286200001
000877948 0247_ $$2altmetric$$aaltmetric:97593548
000877948 037__ $$aFZJ-2020-02527
000877948 082__ $$a540
000877948 1001_ $$0P:(DE-Juel1)180244$$aOlubiyi, Olujide$$b0$$ufzj
000877948 245__ $$aHigh Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2
000877948 260__ $$aBasel$$bMDPI$$c2020
000877948 3367_ $$2DRIVER$$aarticle
000877948 3367_ $$2DataCite$$aOutput Types/Journal article
000877948 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1599660953_20793
000877948 3367_ $$2BibTeX$$aARTICLE
000877948 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000877948 3367_ $$00$$2EndNote$$aJournal Article
000877948 520__ $$aWe use state-of-the-art computer-aided drug design (CADD) techniques to identify prospective inhibitors of the main protease enzyme, 3CLpro of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19. From our screening of over one million compounds including approved drugs, investigational drugs, natural products, and organic compounds, and a rescreening protocol incorporating enzyme dynamics via ensemble docking, we have been able to identify a range of prospective 3CLpro inhibitors. Importantly, some of the identified compounds had previously been reported to exhibit inhibitory activities against the 3CLpro enzyme of the closely related SARS-CoV virus. The top-ranking compounds are characterized by the presence of multiple bi- and monocyclic rings, many of them being heterocycles and aromatic, which are flexibly linked allowing the ligands to adapt to the geometry of the 3CLpro substrate site and involve a high amount of functional groups enabling hydrogen bond formation with surrounding amino acid residues, including the catalytic dyad residues H41 and C145. Among the top binding compounds we identified several tyrosine kinase inhibitors, which include a bioflavonoid, the group of natural products that binds best to 3CLpro. Another class of compounds that decently binds to the SARS-CoV-2 main protease are steroid hormones, which thus may be endogenous inhibitors and might provide an explanation for the age-dependent severity of COVID-19. Many of the compounds identified by our work show a considerably stronger binding than found for reference compounds with in vitro demonstrated 3CLpro inhibition and anticoronavirus activity. The compounds determined in this work thus represent a good starting point for the design of inhibitors of SARS-CoV-2 replication.
000877948 536__ $$0G:(DE-HGF)POF3-551$$a551 - Functional Macromolecules and Complexes (POF3-551)$$cPOF3-551$$fPOF III$$x0
000877948 588__ $$aDataset connected to CrossRef
000877948 7001_ $$0P:(DE-Juel1)176536$$aOlagunju, Maryam$$b1$$ufzj
000877948 7001_ $$0P:(DE-Juel1)180658$$aKeutmann, Monika$$b2$$ufzj
000877948 7001_ $$0P:(DE-Juel1)174397$$aLoschwitz, Jennifer$$b3
000877948 7001_ $$0P:(DE-Juel1)132024$$aStrodel, Birgit$$b4$$eCorresponding author
000877948 773__ $$0PERI:(DE-600)2008644-1$$a10.3390/molecules25143193$$gVol. 25, no. 14, p. 3193 -$$n14$$p3193 -$$tMolecules$$v25$$x1420-3049$$y2020
000877948 8564_ $$uhttps://juser.fz-juelich.de/record/877948/files/Invoice_molecules-838433.pdf
000877948 8564_ $$uhttps://juser.fz-juelich.de/record/877948/files/Invoice_molecules-838433.pdf?subformat=pdfa$$xpdfa
000877948 8564_ $$uhttps://juser.fz-juelich.de/record/877948/files/molecules-25-03193-v2.pdf$$yOpenAccess
000877948 8564_ $$uhttps://juser.fz-juelich.de/record/877948/files/molecules-25-03193-v2.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000877948 8767_ $$8molecules-838433$$92020-07-14$$d2020-07-16$$eAPC$$jZahlung erfolgt$$pmolecules-838433
000877948 909CO $$ooai:juser.fz-juelich.de:877948$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000877948 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)180244$$aForschungszentrum Jülich$$b0$$kFZJ
000877948 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)176536$$aForschungszentrum Jülich$$b1$$kFZJ
000877948 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)180658$$aForschungszentrum Jülich$$b2$$kFZJ
000877948 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)174397$$aForschungszentrum Jülich$$b3$$kFZJ
000877948 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132024$$aForschungszentrum Jülich$$b4$$kFZJ
000877948 9131_ $$0G:(DE-HGF)POF3-551$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vFunctional Macromolecules and Complexes$$x0
000877948 9141_ $$y2020
000877948 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-03
000877948 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000877948 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000877948 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$f2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-01-03
000877948 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-03
000877948 9201_ $$0I:(DE-Juel1)IBI-7-20200312$$kIBI-7$$lStrukturbiochemie$$x0
000877948 980__ $$ajournal
000877948 980__ $$aVDB
000877948 980__ $$aUNRESTRICTED
000877948 980__ $$aI:(DE-Juel1)IBI-7-20200312
000877948 980__ $$aAPC
000877948 9801_ $$aAPC
000877948 9801_ $$aFullTexts